• Sixty-two consecutive septic surgical patients receiving standard multimodal intensive care unit treatment who developed a sepsis score of 20 or greater (day 0) were randomized to receive 0.4 g/kg of either intravenous IgG (29 patients) or human albumin (controls; 33 patients), repeated on days +1 and + 5, in a prospective, double-blind, multicenter study. The two groups were similar in age, initial sepsis scores, and acute physiology and chronic health evaluation II score. A significantly lower mortality was recorded in the IgG-treated group (38%) than in controls (67%). Septic shock was the cause of death in 7% of IgG-treated patients and in 33% of controls. The results of this study indicate that high-dose IgG improves survival and decreases death from septic shock in surgical patients with a sepsis score of 20 or greater.
(Arch Surg. 1991;126:236-240)
Dominioni L, Dionigi R, Zanello M, et al. Effects of High-Dose IgG on Survival of Surgical Patients With Sepsis Scores of 20 or Greater. Arch Surg. 1991;126(2):236–240. doi:10.1001/archsurg.1991.01410260126018
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: